Although several papers have connected the altered expression of MUC1 to epithelial–mesenchymal transition (EMT) (51–54), the impact of atypical O-glycans carried by MUC1 on cancer cells undergoing EMT is still unknown. This evidence concerns the gene MUC1 and cancer.